Name
Purdue University Globle
NU506 Health Policy, Ethical, and Legal Perspectives of the Health Care System
Prof. Name
Date
Risk management and adherence to the nursing standard of care are essential for preventing patient harm, improving healthcare outcomes, and reducing professional and malpractice risks. In nursing practice, effective risk management means identifying potential hazards before they cause harm, following evidence-based clinical standards, maintaining competency, communicating clearly, documenting care accurately, and responding promptly when complications occur. The case of Ms. Yolonda Pinellas illustrates how medication errors, inadequate assessment and monitoring, documentation problems, communication failures, and organizational weaknesses can interact and contribute to serious patient injury.
Risk management in nursing is the systematic process of identifying, evaluating, preventing, and responding to risks that could harm patients or expose healthcare professionals and organizations to liability. The nursing standard of care is the level of care a reasonably competent healthcare professional would be expected to provide under similar clinical circumstances, considering applicable laws, professional standards, evidence-based guidance, and organizational policies.
Patient safety is also an organizational responsibility. Healthcare facilities must establish systems that support safe practice through appropriate staffing, competency-based education, effective policies, adequate resources, and mechanisms for reporting and analyzing safety events. Consequently, effective risk management requires both individual accountability and organizational support.
Risk management is a proactive approach to patient safety. Rather than waiting for an adverse event to occur, nurses and other healthcare professionals identify potential hazards and implement safeguards before treatment begins. This may include reviewing a patient’s medical history, identifying allergies and risk factors, evaluating medication-specific hazards, confirming orders, assessing treatment options, and establishing appropriate monitoring procedures.
For nurse practitioners and other advanced practice providers, risk management also involves using clinical judgment when treatment decisions carry significant risks. Providers must consider the patient’s condition, treatment goals, available evidence, professional scope of practice, and the resources available within the healthcare setting.
The standard of care establishes the professional expectations that apply to a particular clinical situation. It may be informed by:
State laws and nursing regulations
Scope-of-practice requirements
Professional nursing standards
Evidence-based clinical guidelines
Facility policies and procedures
Current scientific literature
Accepted clinical practices
A failure to meet applicable standards may contribute to patient harm and can potentially result in professional, regulatory, or legal consequences.
The nursing process provides a systematic framework for delivering individualized and safe patient care. Applying the nursing process consistently helps nurses recognize changes in patient condition, prioritize risks, select appropriate interventions, and evaluate whether treatment is producing the desired outcome.
The five steps are:
Assessment: Collect comprehensive patient information and identify actual or potential risks.
Diagnosis: Identify patient problems that require nursing intervention.
Planning: Establish individualized goals and interventions based on patient needs and available evidence.
Implementation: Carry out appropriate interventions safely and according to established standards.
Evaluation: Assess patient outcomes and modify the plan of care when necessary.
The nursing process is particularly important when caring for patients receiving high-risk medications because changes in patient condition or treatment complications may require immediate reassessment and intervention.
The Ms. Yolonda Pinellas case demonstrates how patient harm can result from multiple failures rather than one isolated mistake. Medication administration concerns, inadequate assessment, insufficient monitoring, documentation deficiencies, communication problems, and system-level weaknesses may combine to create a chain of events that increases the severity of an adverse outcome.
The case also demonstrates the importance of risk assessment when administering medications that can cause significant tissue injury. Chemotherapy agents classified as vesicants require careful planning because extravasation can result in serious local tissue damage.
Before administering a high-risk medication, healthcare professionals should consider the medication’s properties, the patient’s individual risk factors, the selected vascular access device, required monitoring, staff competency, and the appropriate response if an adverse event occurs.
One important safety concern associated with the case involves Mitomycin, an antineoplastic medication with vesicant properties. A vesicant can cause significant tissue injury if it escapes from the vascular system into surrounding tissue.
Extravasation of a vesicant can cause pain, inflammation, tissue destruction, necrosis, impaired healing, and potentially long-term functional problems. The severity of injury depends on factors such as the medication, concentration, amount of extravasated drug, location, duration of exposure, and speed of intervention.
Safe administration begins before the medication reaches the patient. Healthcare professionals should follow the current medication-specific and institutional extravasation policies rather than relying on a single universal administration method.
Depending on the medication, treatment protocol, patient condition, and institutional policy, vascular access may be peripheral or central. When peripheral administration is used, appropriate assessment, secure access, blood return verification when indicated, frequent monitoring, and adherence to the medication-specific protocol are essential.
Important safety measures include:
Verifying the medication, dose, route, and administration instructions.
Assessing vascular access before and during administration.
Confirming patency and blood return according to applicable protocols.
Monitoring the infusion site and patient symptoms closely.
Educating the patient to report pain, burning, swelling, or other unusual sensations immediately.
Stopping administration promptly when extravasation is suspected.
Following the institution’s medication-specific extravasation procedure.
Risk management should begin before treatment starts. A provider or nurse administering a high-risk medication should anticipate possible complications and determine what resources and interventions would be needed if a problem occurs.
For a patient receiving a vesicant such as Mitomycin, appropriate planning may include evaluating whether the selected vascular access is suitable, confirming that trained personnel are available, reviewing the medication’s extravasation management procedure, and ensuring that communication pathways are clear.
A safe plan may also require collaboration among nurses, prescribers, pharmacists, oncology specialists, and other members of the interdisciplinary healthcare team.
Clinical decision-making is central to nursing risk management. Nurses and advanced practice providers must recognize that treatment decisions involve both benefits and potential risks.
When high-risk medications are involved, clinical decisions should consider:
Patient-specific risk factors
Medication characteristics
Treatment objectives
Vascular access options
Staff competency
Monitoring requirements
Available emergency resources
Current clinical guidance
Clear communication is particularly important because unclear orders, incomplete handoffs, or inconsistent instructions can create opportunities for medication errors and delayed intervention.
Nurses have a critical role in preventing medication-related injuries because they often administer the medication and monitor the patient directly.
Nursing responsibilities may include verifying medication orders, assessing vascular access, monitoring the infusion, identifying early signs of extravasation, educating the patient, communicating concerns, and documenting care.
The nurse should:
Verify the medication and order before administration.
Assess the IV site or vascular access device.
Confirm patency according to applicable protocol.
Monitor the patient throughout administration.
Encourage immediate reporting of pain or unusual sensations.
Recognize signs of infiltration or extravasation.
Stop administration when extravasation is suspected.
Notify the appropriate healthcare professional.
Follow the organization’s extravasation protocol.
Document assessments, interventions, notifications, and patient responses.
Early recognition is one of the most important components of extravasation management. Symptoms may develop during administration or afterward, and not every patient will experience the same findings.
Possible warning signs include:
Burning, stinging, or pain at the administration site
Swelling or edema
Redness or skin discoloration
Leakage around the catheter
Changes in skin temperature or appearance
Resistance to infusion
Reduced or absent blood return when applicable
Patients should be encouraged to immediately report discomfort instead of assuming that pain or burning is a normal part of treatment.
Patient safety cannot depend exclusively on individual nurses. Healthcare organizations are responsible for developing systems that make safe practice possible.
Organizational risk management includes appropriate staffing, competency validation, medication safety policies, access to necessary equipment, effective communication processes, and systems for reporting and reviewing adverse events.
In the Ms. Yolonda Pinellas case, organizational concerns such as staffing limitations, inadequate specialty experience, and insufficient support for complex treatment demonstrate how system-level conditions can increase clinical risk.
Healthcare facilities can reduce preventable patient harm by combining competent staff with appropriate policies, training, supervision, resources, and continuous quality improvement.
Adequate staffing supports timely assessment, monitoring, communication, and intervention. When staffing levels are insufficient, nurses may experience heavier workloads and have fewer opportunities to conduct comprehensive assessments or respond promptly to changes in patient condition.
Staffing problems can contribute to:
Delayed recognition of complications
Reduced monitoring
Increased workload and fatigue
Communication breakdowns
Medication administration errors
Delayed interventions
High-risk clinical areas, including oncology, require personnel with appropriate education and demonstrated competency. Assigning staff to specialized responsibilities without adequate preparation can increase patient safety risks.
Healthcare organizations should ensure that personnel administering specialized treatments have appropriate education and competency. Training should be specific to the medications, procedures, and patient populations involved.
For chemotherapy administration, education may include:
Identifying vesicant medications
Safe administration practices
Vascular access assessment
Recognition of extravasation
Immediate response procedures
Medication-specific management
Documentation requirements
Patient education
Competency validation should be maintained over time. Continuing education and periodic reassessment help healthcare professionals remain familiar with evolving evidence and organizational procedures.
Preventing an adverse event is generally preferable to managing its consequences after it occurs. High-risk medications therefore require a structured safety process before administration.
Healthcare professionals should assess the medication, patient, vascular access, environment, personnel competency, monitoring requirements, and emergency response plan.
Vascular access selection should be based on the medication, treatment plan, patient-specific factors, institutional policy, and current clinical guidance.
For vesicant chemotherapy, clinicians should evaluate whether peripheral or central access is appropriate for the specific medication and circumstances. The access device should be functional, appropriately positioned, and carefully assessed before and during administration.
The goal is not simply to select a particular type of catheter but to ensure that the chosen route and device are appropriate for the medication and that the patient can be safely monitored throughout treatment.
Medication safety extends beyond confirming the correct drug and dose. Healthcare professionals should understand the medication’s administration requirements, adverse effects, compatibility considerations, monitoring needs, and emergency procedures.
A standardized safety process can include:
Reviewing medication-specific administration guidance.
Verifying the prescription and patient information.
Assessing vascular access.
Monitoring the administration site.
Educating the patient.
Maintaining appropriate observation during treatment.
Responding immediately to suspected complications.
Documenting care according to policy.
Standardized processes reduce unnecessary variation and help healthcare teams respond consistently to high-risk situations.
Patient education is an important component of medication safety. Patients receiving chemotherapy should understand which symptoms need to be reported immediately.
Before and during treatment, patients should be encouraged to report pain, burning, swelling, redness, tightness, leakage, or other unusual sensations around the administration site.
Patient participation provides an additional layer of safety because patients may notice symptoms before visible changes become obvious to healthcare staff.
Effective communication between patients and healthcare professionals can help prevent complications from becoming more severe.
Nurses should create an environment in which patients feel comfortable reporting symptoms immediately. Patients should not be encouraged to tolerate unexplained pain or assume that discomfort is expected during an infusion.
Clear communication should also occur among nurses, prescribers, pharmacists, and other healthcare professionals involved in the patient’s care.
Preventive measures cannot eliminate every adverse event. When an event occurs, rapid clinical assessment and appropriate intervention are essential.
A comprehensive post-event response should address the patient’s immediate clinical needs while also ensuring accurate documentation, timely communication, appropriate follow-up, and evaluation of the factors that contributed to the event.
When extravasation is suspected, healthcare professionals should follow the current medication-specific institutional protocol. In general, administration should be stopped promptly, while the catheter may initially be left in place when required for aspiration or other protocol-directed interventions.
The response may include:
Stopping the infusion immediately.
Leaving the device in place initially when required by the applicable protocol.
Attempting aspiration through the existing device when indicated.
Assessing and documenting the affected area.
Notifying the appropriate provider.
Initiating medication-specific treatment.
Consulting specialists when indicated.
Monitoring the patient.
Providing appropriate follow-up.
Because management differs according to the medication involved, healthcare professionals should not rely on a generic extravasation procedure when a medication-specific protocol is available.
Documentation is an essential component of patient safety, communication, and professional accountability. A clear clinical record helps subsequent healthcare professionals understand what happened and what treatment was provided.
Documentation should accurately reflect:
Date and time of the event
Medication involved
Dose and administration information when relevant
Vascular access location and type
Patient symptoms
Assessment findings
Appearance and location of the affected area
Interventions performed
Healthcare professionals notified
Patient response
Follow-up plan
Documentation should be objective, timely, complete, and consistent with organizational policy.
Accurate clinical documentation supports continuity of care and provides a record of assessments, clinical decisions, interventions, and patient outcomes.
The severity of tissue injury should be evaluated clinically, with additional diagnostic testing used when appropriate. Depending on the severity and clinical presentation, patients may require wound care, specialist consultation, imaging, or surgical evaluation.
The purpose of evaluation is to determine the extent of injury, identify complications, monitor progression, and guide treatment.
Diagnostic imaging should be selected based on the clinical situation rather than automatically performed for every extravasation event.
Nurse practitioners have professional responsibilities to provide safe, competent, ethical, and evidence-based care. These responsibilities include practicing within their scope, maintaining competency, communicating clinically significant information, documenting appropriately, and advocating for patient safety.
Depending on applicable law and professional requirements, responsibilities may include:
Practicing within the authorized scope of practice
Following applicable professional standards and regulations
Maintaining clinical competency
Using evidence-based decision-making
Communicating relevant patient information
Reporting unsafe conditions when required
Maintaining accurate documentation
Advocating for patient safety
Following organizational policies and procedures
Failure to meet applicable professional or legal requirements may contribute to disciplinary action, malpractice claims, or other professional consequences.
Risk management should continue after an adverse event has been addressed. Healthcare organizations should examine why an event occurred and determine whether changes to policies, training, staffing, communication, or workflow could reduce the likelihood of recurrence.
Quality improvement strategies may include:
Root cause analysis or other event-review processes
Review of medication administration practices
Updating policies and protocols
Continuing staff education
Competency reassessment
Interdisciplinary collaboration
Monitoring compliance with safety procedures
Improving handoff and communication systems
Encouraging appropriate safety-event reporting
A strong culture of safety encourages healthcare professionals to identify hazards before they result in patient harm and to report problems without fear of inappropriate retaliation.
Safe nursing care is a shared responsibility. Individual clinicians must use sound judgment, follow applicable standards, communicate effectively, and maintain competency. Organizations must provide the staffing, education, policies, equipment, and systems necessary for clinicians to perform those responsibilities safely.
When both levels work together, healthcare organizations are better positioned to identify hazards, prevent errors, respond to adverse events, and improve patient outcomes.
Risk management and adherence to the nursing standard of care are fundamental to patient safety and high-quality healthcare. The Ms. Yolonda Pinellas case illustrates how medication administration problems, inadequate assessment and monitoring, communication failures, documentation concerns, and organizational weaknesses can interact to produce serious patient harm.
Nurses and nurse practitioners can reduce preventable risks by using systematic assessment, evidence-based clinical judgment, appropriate medication-safety practices, patient education, effective communication, timely intervention, and accurate documentation. Healthcare organizations must reinforce these efforts through adequate staffing, specialized training, competency validation, standardized procedures, and continuous quality improvement.
Ultimately, effective nursing risk management is proactive rather than reactive. Identifying hazards early, following applicable standards, and creating reliable systems for responding to complications can help protect patients while supporting safer and more accountable nursing practice.
Risk management in nursing is the systematic process of identifying, assessing, preventing, and responding to risks that could cause patient harm or create professional and organizational liability. It includes safe medication practices, clinical assessment, evidence-based care, communication, documentation, and quality improvement.
The nursing standard of care refers to the level of professional care that would reasonably be expected from a competent healthcare professional in a similar clinical situation. The applicable standard may be influenced by professional standards, laws and regulations, evidence-based guidance, facility policies, and accepted clinical practice.
Mitomycin has vesicant properties, meaning that extravasation can cause significant local tissue injury. Depending on the circumstances, tissue damage may include inflammation, necrosis, impaired healing, and other serious complications. Careful administration and prompt response to suspected extravasation are therefore important.
Nurses can reduce professional risk by practicing within their scope of practice, following applicable standards and policies, maintaining competency, performing appropriate assessments, communicating concerns, educating patients, recognizing complications promptly, and documenting care accurately.
Documentation provides a contemporaneous clinical record of patient assessments, decisions, interventions, communications, and outcomes. It supports continuity of care and helps healthcare professionals understand the patient’s condition and treatment history.
The nurse should stop administration promptly and follow the medication-specific extravasation protocol used by the healthcare organization. Depending on the medication and protocol, the vascular access device may initially remain in place for aspiration or other indicated interventions. The event should be assessed, managed, communicated, and documented promptly.
Possible signs include pain, burning, stinging, swelling, redness, leakage, skin changes, resistance to infusion, or changes in blood return when applicable. Patients should be encouraged to report unusual sensations immediately.
Healthcare facilities should establish systems that support safe care. These responsibilities can include appropriate staffing, competency-based education, medication-safety procedures, clear communication processes, adequate resources, event reporting, and continuous quality improvement.
The nursing process supports risk management through systematic assessment, identification of patient problems, individualized planning, safe implementation, and ongoing evaluation. This framework helps nurses recognize changes in patient condition and modify care when necessary.
American Nurses Association. (2015). Code of ethics for nurses with interpretive statements. American Nurses Association. https://www.nursingworld.org/coe-view-only
American Nurses Association. (2021). Nursing: Scope and standards of practice (4th ed.). American Nurses Association.
National Cancer Institute. (n.d.). Extravasation. National Cancer Institute. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/extravasation
National Cancer Institute. (n.d.). Mitomycin. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/drugs/mitomycin
Occupational Safety and Health Administration. (n.d.). Healthcare wide hazards: Hazardous drugs. U.S. Department of Labor. https://www.osha.gov/healthcare/hazardous-drugs
Polovich, M., Olsen, M., & LeFebvre, K. B. (Eds.). (2014). Chemotherapy and biotherapy guidelines and recommendations for practice (4th ed.). Oncology Nursing Society.
The Joint Commission. (n.d.). National Patient Safety Goals. https://www.jointcommission.org/standards/national-patient-safety-goals/
U.S. Pharmacopeia. (n.d.). General chapter <797>: Pharmaceutical compounding—Sterile preparations. https://www.usp.org/compounding/general-chapter-797
World Health Organization. (2021). Global patient safety action plan 2021–2030: Towards eliminating avoidable harm in health care. World Health Organization. https://www.who.int/publications/i/item/9789240032705
